Evidence map›Paper›PMID 32950407›Full record

ArticleBrachytherapy

Development, implementation, and associated challenges of a new HDR brachytherapy program.

Daniel J Scanderbeg, Catheryn Yashar, Zoubir Ouhib, Anuja Jhingran, John Einck

Abstract read
In one paragraph

Article in Brachytherapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Daniel J ScanderbegRadiation Medicine and Applied Sciences, University of California, San Diego, CA. Electronic address: dscanderbeg@health.ucsd.edu.
Catheryn YasharRadiation Medicine and Applied Sciences, University of California, San Diego, CA.
Zoubir OuhibRadiation Oncology, Lynn Regional Cancer Center, Delray Beach, FL.
Anuja JhingranRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
John EinckRadiation Medicine and Applied Sciences, University of California, San Diego, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing any new radiation oncology program requires planning and analysis of the current state of the facility and its capacity to take on another program. Staff must consider a large number of factors to establish a feasible, safe, and sustainable program. We present a simple and generic outline that lays out the process for developing and implementing a new HDR brachytherapy program in any setting, but with particular emphasis on challenges associated with starting the program in a limited resource setting. The sections include feasibility of a program, starting cases, machine and equipment selection, and quality and safety.

Indexed as

BrachytherapyHumansProgram DevelopmentQuality Assurance, Health CareRadiation OncologyRadiotherapy DosageSafety ManagementBrachytherapyHDRImplementing new treatment techniquesInternationalLimited resource settingQuality and safety

Identifiers

PMID32950407
PMCPMC7495265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.